ArticleNeuro-oncology advances

Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.

Liying Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.